Advertisement
UK markets close in 2 hours 4 minutes
  • FTSE 100

    8,280.07
    +42.35 (+0.51%)
     
  • FTSE 250

    20,539.57
    +97.22 (+0.48%)
     
  • AIM

    772.63
    +0.06 (+0.01%)
     
  • GBP/EUR

    1.1804
    -0.0018 (-0.15%)
     
  • GBP/USD

    1.2677
    +0.0032 (+0.25%)
     
  • Bitcoin GBP

    48,199.73
    -2,501.44 (-4.93%)
     
  • CMC Crypto 200

    1,262.27
    -47.45 (-3.62%)
     
  • S&P 500

    5,464.62
    -8.55 (-0.16%)
     
  • DOW

    39,150.33
    +15.53 (+0.04%)
     
  • CRUDE OIL

    80.36
    -0.37 (-0.46%)
     
  • GOLD FUTURES

    2,339.10
    +7.90 (+0.34%)
     
  • NIKKEI 225

    38,804.65
    +208.18 (+0.54%)
     
  • HANG SENG

    18,027.71
    -0.81 (-0.00%)
     
  • DAX

    18,275.39
    +111.87 (+0.62%)
     
  • CAC 40

    7,690.43
    +61.86 (+0.81%)
     

Is CareCloud (CCLD) Stock Outpacing Its Medical Peers This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is CareCloud, Inc. (CCLD) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

CareCloud, Inc. is one of 1044 individual stocks in the Medical sector. Collectively, these companies sit at #8 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. CareCloud, Inc. is currently sporting a Zacks Rank of #2 (Buy).

Within the past quarter, the Zacks Consensus Estimate for CCLD's full-year earnings has moved 130.3% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

ADVERTISEMENT

According to our latest data, CCLD has moved about 73.7% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of 5.7% on a year-to-date basis. This means that CareCloud, Inc. is performing better than its sector in terms of year-to-date returns.

Context Therapeutics Inc. (CNTX) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 81.4%.

Over the past three months, Context Therapeutics Inc.'s consensus EPS estimate for the current year has increased 37.8%. The stock currently has a Zacks Rank #2 (Buy).

Looking more specifically, CareCloud, Inc. belongs to the Medical Info Systems industry, a group that includes 43 individual stocks and currently sits at #67 in the Zacks Industry Rank. Stocks in this group have lost about 20.2% so far this year, so CCLD is performing better this group in terms of year-to-date returns.

Context Therapeutics Inc. however, belongs to the Medical - Drugs industry. Currently, this 185-stock industry is ranked #84. The industry has moved -6.2% so far this year.

Investors with an interest in Medical stocks should continue to track CareCloud, Inc. and Context Therapeutics Inc. These stocks will be looking to continue their solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CareCloud, Inc. (CCLD) : Free Stock Analysis Report

Context Therapeutics Inc. (CNTX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research